Clinical Trials Browser

Enrolling by invitation × INDUSTRY × Advanced Solid Tumor × Clear all

NCT06169579 2024-11-15

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers

Phase 1 Enrolling by invitation

Other solid neoplasm

Advanced Solid Tumor

NCT06205082 2024-03-01

A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor

Phase 1 Enrolling by invitation

Other solid neoplasm

Advanced Solid Tumor